Table I.
t [min] | Control | Amiodarone | P-value** | Amiodarone + Vit. C | Amiodarone + NAC | Amiodarone + Vit. E |
---|---|---|---|---|---|---|
1 | 584.2 ±91.2 | 150.5 ±87.1 | < 0.0001 | 321.4 ±126.1 p*** < 0.0001 |
332.8 ±118.7 p*** < 0.0001 |
372.7 ±92.0 p*** < 0.0001 |
2 | 607.7 ±91.4 | 162.2 ±96.3 | < 0.0001 | 334.3 ±134.1 p*** < 0.0001 |
345.7 ±125.6 p*** < 0.0001 |
386.8 ±95.2 p*** < 0.0001 |
3 | 627.0 ±88.2 | 176.3 ±104.7 | < 0.0001 | 347.7 ±142.7 p*** < 0.0001 |
360.1 ±132.8 p*** < 0.0001 |
402.3 ±99.2 p*** < 0.0001 |
4 | 644.3 ±83.6 | 188.8 ±113.8 | < 0.0001 | 363.6 ±151.5 p*** < 0.0001 |
375.5 ±140.0 p*** < 0.0001 |
419.7 ±104.4 p*** < 0.0001 |
5 | 659.4 ±77.4 | 205.4 ±122.5 | < 0.0001 | 380.0 ±157.7 p*** < 0.0001 |
392.8 ±147.4 p*** < 0.0001 |
440.6 ±109.3 p*** < 0.0001 |
P-value* | < 0.0001 | < 0.0001 | < 0.0001 | < 0.0001 | < 0.0001 |
2-way ANOVA
comparison between control vs. amiodarone groups/Bonferroni adjusted Mann-Whitney U
comparison between groups vs. amiodarone group/Bonferroni adjusted Mann-Whitney U.
All data are presented as mean ± SD. The level of significance was taken as p < 0.05. t – time, Vit. C – vitamin C, NAC – N-acetyl cysteine, Vit. E – vitamin E.